StockNews.com assumed coverage on shares of Retractable Technologies (NYSE:RVP – Free Report) in a research note released on ...

ISMP reported confusion between tetanus diphtheria toxoid (Td) and tuberculin purified protein ... Lack of availability of Td in single-dose syringes also forces providers to purchase multiple ...

Leading UCSF physician-scientists are developing targeted treatments, earlier diagnostics, and helping to solve tuberculosis’ ...

STEQEYMA®, one of the first-wave biosimilars to STELARA®, is now available in the U.S. Approved for the same indications as ...

The subcutaneous injection comes in two strengths: 45mg/0.5 mL or 90mg/1 mL solution in a single-dose, prefilled syringe. The intravenous infusion is provided as a 130mg/26 mL (5mg/mL) solution in ...

After hours: March 12 at 5:59:00 PM EDT Loading Chart for RVP ...

SAN FRANCISCO — New data suggest that lenacapavir delivered just once per year could be as effective for HIV prevention as the twice-yearly injections already under review by the FDA.

Scientists dive into the genomes of whales, elephants, and other animal giants looking for new weapons in the fight against cancer.

'Unacceptable': Fiji Rugby demands answers following Drua's mistreatment in NZ ...